Shevanthi Nayagam

5.3k total citations
38 papers, 1.7k citations indexed

About

Shevanthi Nayagam is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Shevanthi Nayagam has authored 38 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 27 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Shevanthi Nayagam's work include Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (14 papers). Shevanthi Nayagam is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (14 papers). Shevanthi Nayagam collaborates with scholars based in United Kingdom, France and Gambia. Shevanthi Nayagam's co-authors include Mark Thursz, Timothy B. Hallett, Maud Lemoine, Graham Cooke, Elisa Sicuri, Lesong Conteh, Yusuke Shimakawa, Stefan Z. Wiktor, Daniel Low‐Beer and Panagiotis Vlavianos and has published in prestigious journals such as The Lancet, Nature Communications and PLoS ONE.

In The Last Decade

Shevanthi Nayagam

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shevanthi Nayagam United Kingdom	17	1.2k	1.0k	320	272	233	38	1.7k
Kathleen N. Ly United States	16	1.7k 1.4×	1.7k 1.7×	271 0.8×	287 1.1×	142 0.6×	30	2.5k
Hsu‐Sung Kuo Taiwan	19	863 0.7×	500 0.5×	173 0.5×	179 0.7×	98 0.4×	28	1.4k
C Wendy Spearman South Africa	20	798 0.7×	835 0.8×	87 0.3×	247 0.9×	212 0.9×	89	1.4k
Tram T. Tran United States	24	1.7k 1.4×	1.5k 1.4×	108 0.3×	241 0.9×	371 1.6×	84	2.5k
William Wong Canada	20	741 0.6×	597 0.6×	148 0.5×	139 0.5×	92 0.4×	92	1.3k
Lesley S. Park United States	19	600 0.5×	244 0.2×	543 1.7×	642 2.4×	182 0.8×	36	1.7k
Brittney Baack United States	14	1.4k 1.1×	1.3k 1.2×	146 0.5×	422 1.6×	62 0.3×	21	2.1k
Giovanni Battista Gaeta Italy	29	2.7k 2.2×	2.5k 2.5×	172 0.5×	306 1.1×	200 0.9×	113	3.4k
Yinlian Wu China	15	714 0.6×	261 0.3×	248 0.8×	649 2.4×	115 0.5×	28	1.6k
Hla‐Hla Thein Canada	24	1.6k 1.3×	1.4k 1.4×	87 0.3×	339 1.2×	200 0.9×	61	2.4k

Countries citing papers authored by Shevanthi Nayagam

Since Specialization

Citations

This map shows the geographic impact of Shevanthi Nayagam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shevanthi Nayagam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shevanthi Nayagam more than expected).

Fields of papers citing papers by Shevanthi Nayagam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shevanthi Nayagam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shevanthi Nayagam. The network helps show where Shevanthi Nayagam may publish in the future.

Co-authorship network of co-authors of Shevanthi Nayagam

This figure shows the co-authorship network connecting the top 25 collaborators of Shevanthi Nayagam. A scholar is included among the top collaborators of Shevanthi Nayagam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shevanthi Nayagam. Shevanthi Nayagam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fu, Michael X., Amelia Cook, Gibril Ndow, et al.. (2025). Quality of life in patients with HBV infection: A systematic review and meta-analysis. JHEP Reports. 7(4). 101312–101312. 2 indexed citations

Villiers, Margaret J. de, Ethel‐Michele de Villiers, Shevanthi Nayagam, & Timothy B. Hallett. (2024). Direct and indirect effects of hepatitis B vaccination in four low- and middle-income countries. Epidemics. 49. 100798–100798. 1 indexed citations

Ségéral, Olivier, et al.. (2024). Proportion of pregnant women with HBV infection eligible for antiviral prophylaxis to prevent vertical transmission: A systematic review and meta-analysis. JHEP Reports. 6(8). 101064–101064. 1 indexed citations

Schmit, Nora, Shevanthi Nayagam, Maud Lemoine, et al.. (2023). Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia. Journal of Global Health. 13. 4004–4004. 2 indexed citations

Nguyen, Liêm Binh Luong, Maud Lemoine, Gibril Ndow, et al.. (2023). Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet Global Health. 12(1). e66–e78. 8 indexed citations

Nayagam, Shevanthi, Margaret J. de Villiers, Yusuke Shimakawa, et al.. (2023). Impact and cost-effectiveness of hepatitis B virus prophylaxis in pregnancy: a dynamic simulation modelling study. The Lancet. Gastroenterology & hepatology. 8(7). 635–645. 15 indexed citations

Mohamed, Zameer, Nick Scott, Shevanthi Nayagam, et al.. (2021). Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, Tanzania. International Journal of Drug Policy. 99. 103458–103458. 5 indexed citations

Vollmer, Michaela, Mara D. Kont, Seth Flaxman, et al.. (2021). The impact of the COVID-19 pandemic on patterns of attendance at emergency departments in two large London hospitals: an observational study. BMC Health Services Research. 21(1). 1008–1008. 26 indexed citations

Echeverría-Londoño, Susy, Xiang Li, Jaspreet Toor, et al.. (2021). How can the public health impact of vaccination be estimated?. BMC Public Health. 21(1). 2049–2049. 14 indexed citations

10.

Villiers, Margaret J. de, Shevanthi Nayagam, & Timothy B. Hallett. (2021). The impact of the timely birth dose vaccine on the global elimination of hepatitis B. Nature Communications. 12(1). 6223–6223. 60 indexed citations

11.

Middleton, Paul, Pablo N. Perez‐Guzman, Mara D. Kont, et al.. (2021). Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study. Scientific Reports. 11(1). 2455–2455. 10 indexed citations

12.

Villiers, Margaret J. de, Ivane Gamkrelidze, Timothy B. Hallett, et al.. (2020). Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models. PLoS ONE. 15(8). e0237525–e0237525. 7 indexed citations

13.

McCabe, Ruth, Nora Schmit, Joshua C D'Aeth, et al.. (2020). Adapting hospital capacity to meet changing demands during the COVID-19 pandemic. BMC Medicine. 18(1). 329–329. 130 indexed citations

14.

Forlano, Roberta, Benjamin H. Mullish, Sujit Mukherjee, et al.. (2020). In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19. PLoS ONE. 15(10). e0240400–e0240400. 51 indexed citations

15.

Nayagam, Shevanthi, Elisa Sicuri, Maud Lemoine, et al.. (2017). Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries. BMC Infectious Diseases. 17(S1). 692–692. 12 indexed citations

16.

Nayagam, Shevanthi, Mark Thursz, Elisa Sicuri, et al.. (2016). Requirements for global elimination of hepatitis B: a modelling study. The Lancet Infectious Diseases. 16(12). 1399–1408. 261 indexed citations

17.

Nayagam, Shevanthi, Lesong Conteh, Elisa Sicuri, et al.. (2016). Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis. The Lancet Global Health. 4(8). e568–e578. 78 indexed citations

18.

Lemoine, Maud, Yusuke Shimakawa, Shevanthi Nayagam, et al.. (2015). The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa. Gut. 65(8). 1369–1376. 256 indexed citations

19.

Lemoine, Mathilde, Yusuke Shimakawa, Robert Goldin, et al.. (2014). P1019 VALIDATION AND COMPARISON OF NON-INVASIVE MARKERS OF LIVER FIBROSIS IN WEST-AFRICAN PATIENTS WITH CHRONIC HEPATITIS B LIVING IN THE GAMBIA. Journal of Hepatology. 60(1). S414–S415. 2 indexed citations

20.

Nayagam, Shevanthi, Nowlan Selvapatt, Horace R. Williams, et al.. (2012). OC-138 Quality of colonoscopic procedures among independently practising gastroenterology trainees in a NW London cohort: are they reaching national standards?. Gut. 61(Suppl 2). A59.3–A60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact